Patients who received genetically marked CTLs
| UPN . | Diagnosis . | Transplantation . | Status . | Follow-up . | Persistence, months . |
|---|---|---|---|---|---|
| 227 | CML (CP2) | 4/6 MMFM | Died (sepsis) | 187 days | 6 |
| 221 | ALL (CR3) | 6/6 MUD | Alive | 15 years | 105 |
| 219 | ALL (CR2) | 6/6 MUD | Alive | 15 years | 85 |
| 239 | AML in relapse | 4/6 MMFM | Alive | 15 years | 44 |
| 240 | ALL in relapse | 6/6 MUD | Died (relapse) | 99 days | 1 |
| 230 | CML (CP1) | 6/6 MUD | Alive | 14 years | 12 |
| 238 | Secondary AML | 6/6 MUD | Died (relapse) | 873 days | 6 |
| 253 | Secondary AML | 6/6 MUD | Alive | 14 years | Never detected |
| 259 | Secondary AML | 5/6 MUD | Died (relapse) | 154 days | 1 |
| 269 | CML (CP1) | 5/6 MMFM | Died (sepsis) | 239 days | 3 |
| 277 | AML in relapse | 6/6 MUD | Alive | 14 years | 57 |
| 282 | CML (AP) | 5/6 MUD | Alive | 14 years | 55 |
| 293 | CML (CP1) | 6/6 MUD | Alive | 13 years | 70 |
| 296 | MDS | 6/6 MUD | Alive | 13 years | 37 |
| 303 | Secondary AML | 6/6 MUD | Died (relapse) | 196 days | 4 |
| 308 | Secondary AML | 6/6 MUD | Alive | 13 years | 80 |
| 314 | ALL (CR2) | 4/6 MMFM | Alive | 13 years | 78 |
| 318 | MDS | 6/6 MUD | Alive | 13 years | 45 |
| 337 | ALL (CR1) | 5/6 MUD | Died (motor vehicle accident) | 10 years | 82 |
| 317 | AML in relapse | 5/6 MUD | Died (relapse) | 283 days | 1 |
| 345 | MDS | 6/6 MUD | Alive | 13 years | 8 |
| 324 | MDS | 6/6 MUD | Alive | 13 years | 55 |
| 347 | CML (CP1) | 5/6 MUD | Alive | 13 years | 72 |
| 327 | ALL (CR3) | 6/6 MUD | Alive | 13 years | 53 |
| 332 | ALL (CR1) | 5/6 MUD | Died (relapse) | 714 days | 5 |
| 365 | CML (CP1) | 5/6 MUD | Alive | 13 years | 46 |
| UPN . | Diagnosis . | Transplantation . | Status . | Follow-up . | Persistence, months . |
|---|---|---|---|---|---|
| 227 | CML (CP2) | 4/6 MMFM | Died (sepsis) | 187 days | 6 |
| 221 | ALL (CR3) | 6/6 MUD | Alive | 15 years | 105 |
| 219 | ALL (CR2) | 6/6 MUD | Alive | 15 years | 85 |
| 239 | AML in relapse | 4/6 MMFM | Alive | 15 years | 44 |
| 240 | ALL in relapse | 6/6 MUD | Died (relapse) | 99 days | 1 |
| 230 | CML (CP1) | 6/6 MUD | Alive | 14 years | 12 |
| 238 | Secondary AML | 6/6 MUD | Died (relapse) | 873 days | 6 |
| 253 | Secondary AML | 6/6 MUD | Alive | 14 years | Never detected |
| 259 | Secondary AML | 5/6 MUD | Died (relapse) | 154 days | 1 |
| 269 | CML (CP1) | 5/6 MMFM | Died (sepsis) | 239 days | 3 |
| 277 | AML in relapse | 6/6 MUD | Alive | 14 years | 57 |
| 282 | CML (AP) | 5/6 MUD | Alive | 14 years | 55 |
| 293 | CML (CP1) | 6/6 MUD | Alive | 13 years | 70 |
| 296 | MDS | 6/6 MUD | Alive | 13 years | 37 |
| 303 | Secondary AML | 6/6 MUD | Died (relapse) | 196 days | 4 |
| 308 | Secondary AML | 6/6 MUD | Alive | 13 years | 80 |
| 314 | ALL (CR2) | 4/6 MMFM | Alive | 13 years | 78 |
| 318 | MDS | 6/6 MUD | Alive | 13 years | 45 |
| 337 | ALL (CR1) | 5/6 MUD | Died (motor vehicle accident) | 10 years | 82 |
| 317 | AML in relapse | 5/6 MUD | Died (relapse) | 283 days | 1 |
| 345 | MDS | 6/6 MUD | Alive | 13 years | 8 |
| 324 | MDS | 6/6 MUD | Alive | 13 years | 55 |
| 347 | CML (CP1) | 5/6 MUD | Alive | 13 years | 72 |
| 327 | ALL (CR3) | 6/6 MUD | Alive | 13 years | 53 |
| 332 | ALL (CR1) | 5/6 MUD | Died (relapse) | 714 days | 5 |
| 365 | CML (CP1) | 5/6 MUD | Alive | 13 years | 46 |
CTL indicates cytotoxic T lymphocyte; UPN, unique patient number; CML, chronic myeloid leukemia; ALL, acute lymphoid leukemia; AML, acute myeloid leukemia; MDS, myelodysplasia; MMFM, mismatched family donor; MUD, matched unrelated donor; CR, complete remission; CP, chronic phase; and AP, accelerated phase.